KALA BIO
KALA
63 hedge funds and large institutions have $80.7M invested in KALA BIO in 2019 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 24 increasing their positions, 14 reducing their positions, and 8 closing their positions.
1,025% more call options, than puts
Call options by funds: $2.25M | Put options by funds: $200K
71% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 14
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% less ownership
Funds ownership: 0.03% → 0.03% (-0%)
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
4% less capital invested
Capital invested by funds: $84.4M → $80.7M (-$3.71M)
2% less funds holding
Funds holding: 64 → 63 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Manhattan
New York
|
+$1.83M |
| 2 |
PVI
Pura Vida Investments
New York
|
+$782K |
| 3 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$724K |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$338K |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$290K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.55M |
| 2 |
PVMCV
Polaris Venture Management Co V
Boston,
Massachusetts
|
-$2.44M |
| 3 |
BlackRock
New York
|
-$1.29M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$454K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$239K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Fifth Third Bancorp
Cincinnati,
Ohio
| – | -$5K | -1 | Closed |
|
|
MAM
77
Meeder Asset Management
Dublin,
Ohio
| – | -$8K | -1 | Closed |
|
78
Victory Capital Management
San Antonio,
Texas
| – | -$14K | -1 | Closed |
|
79
Daiwa Securities Group
Tokyo,
Japan
| – | -$1K | – | – |
|
|
IUHSA
80
Itau Unibanco Holding S.A.
Sao Paulo,
Brazil
| – | -$6K | – | – |
|
KALA Hedge Fund Activity: Q4 2019 in Review
63 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q4 2019, worth a combined $80.7M — down 4.4% from $84.4M a quarter earlier.
Fund positioning in KALA was balanced in Q4 2019: 8 funds opened new positions, 8 closed out, 24 added to existing stakes and 14 trimmed.
The largest buyer was First Manhattan, opening a new position worth an estimated $1.83M. The largest seller was Wellington Management Group, exiting entirely with an estimated $5.55M sold.
- 63 institutional investors held KALA BIO (KALA) as of Q4 2019, down from 64 in Q3 2019.
- Funds reported $80.7M of KALA BIO stock for Q4 2019, down 4.4% quarter-over-quarter.
- 8 funds opened new KALA BIO positions in Q4 2019 and 8 closed out, a net change of 0 holders.
- The largest KALA BIO buyer in Q4 2019 was First Manhattan, an estimated $1.83M added.
- The largest KALA BIO seller in Q4 2019 was Wellington Management Group, an estimated $5.55M sold.
Based on aggregated 13F filings for Q4 2019.